- Home
- ATNM vs ISPO Comparison
ATNM vs ISPO Comparison
Compare ATNM & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- ISPO
- Stock Information
- Founded
- ATNM 2000
- ISPO 2010
- Country
- ATNM United States
- ISPO United States
- Employees
- ATNM N/A
- ISPO N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- ISPO Blank Checks
- Sector
- ATNM Health Care
- ISPO Finance
- Exchange
- ATNM Nasdaq
- ISPO Nasdaq
- Market Cap
- ATNM 50.2M
- ISPO 44.3M
- IPO Year
- ATNM N/A
- ISPO N/A
- Fundamental
- Price
- ATNM $1.63
- ISPO $3.01
- Analyst Decision
- ATNM Strong Buy
- ISPO
- Analyst Count
- ATNM 2
- ISPO 0
- Target Price
- ATNM $4.50
- ISPO N/A
- AVG Volume (30 Days)
- ATNM 130.6K
- ISPO 153.4K
- Earning Date
- ATNM 11-13-2025
- ISPO 10-27-2025
- Dividend Yield
- ATNM N/A
- ISPO N/A
- EPS Growth
- ATNM N/A
- ISPO N/A
- EPS
- ATNM N/A
- ISPO N/A
- Revenue
- ATNM N/A
- ISPO $261,225,000.00
- Revenue This Year
- ATNM N/A
- ISPO N/A
- Revenue Next Year
- ATNM N/A
- ISPO $148.66
- P/E Ratio
- ATNM N/A
- ISPO N/A
- Revenue Growth
- ATNM N/A
- ISPO N/A
- 52 Week Low
- ATNM $1.03
- ISPO $2.19
- 52 Week High
- ATNM $2.41
- ISPO $7.17
- Technical
- Relative Strength Index (RSI)
- ATNM 46.73
- ISPO 49.98
- Support Level
- ATNM $1.52
- ISPO $2.86
- Resistance Level
- ATNM $1.70
- ISPO $3.38
- Average True Range (ATR)
- ATNM 0.07
- ISPO 0.25
- MACD
- ATNM -0.01
- ISPO 0.00
- Stochastic Oscillator
- ATNM 36.71
- ISPO 34.67
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.